UroGen presents at TD Cowen conference; no material updates provided

UroGen Pharma Ltd.

Presentation furnished as Exhibit 99.1 for TD Cowen 44th Annual Health Care Conference on March 4, 2024.
Title slide states: 'Developing Innovative Medicines to Treat Urothelial Cancers'.
No specific financial, clinical, or guidance data included in the filing or exhibit excerpt.
Filing is procedural Regulation FD disclosure; no new material events reported.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.